Comparison of four direct homogeneous methods for the measurement of low-density lipoprotein cholesterol

Clinical Laboratory

Volumn 56, Issue 7-8, 2010, Pages 327-333

  Yamada, Koji ^a   Tsuji, Naoki ^a,b   Fujita, Tomoko ^c   Tanaka, Maki ^a,b   Kuribayashi, Kageaki ^a,b   Kobayashi, Daisuke ^a,b   Watanabe, Naoki ^a,b  

^a SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kyowa Medex Co Ltd   (Japan)

Author keywords

Direct homogenous assay; Friedewald equation; IDL; LDL C; Routine examinations; VLDL

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; SCHOOL CHILD; BLOOD; BLOOD ANALYSIS; COMPARATIVE STUDY; EVALUATION; HYPERLIPOPROTEINEMIA; MIDDLE AGED; REPRODUCIBILITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; CHILD; CHOLESTEROL, LDL; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 77957333778     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89:525-84.
2. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
3. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995;41:1414-20.
4. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990;36:15-9.
5. Usui S, Kakuuchi H, Okamoto M, Mizukami Y, Okazaki M. Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC. Clin Chem 2002; 48:1946-54. (Pubitemid 35222753)
6. Pietzsch J, Subat S, Nitzsche S, Leonhardt W, Schentke KU, Hanefeld M. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition. Biochim Biophys Acta 1995;1254:77-88.
7. Usui S, Hara Y, Hosaki S, Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 2002;43:805-14. (Pubitemid 34477908)
8. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9. (Pubitemid 26338729)
9. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.